Wenxia Si
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
-
- Circular RNAs in diseases
- RNA modifications and cancer
- Extracellular vesicles in disease
- Angiogenesis and VEGF in Cancer
- Epigenetics and DNA Methylation
Papers in
-
- Ubiquitin and proteasome pathways 2
- Histone Deacetylase Inhibitors Research 2
-
- Cancer, Hypoxia, and Metabolism 4
- MicroRNA in disease regulation 3
- Cancer-related molecular mechanisms research 2
- Co-authors
- Bisheng Zhou (4 shared papers)Xu Yan (2 shared papers)Xin Tu (1 shared paper)Sisi Li (1 shared paper)Ruihua Ma (1 shared paper)Qing Wang (1 shared paper)Zhenhong Su (4 shared papers)Qing K. Wang (4 shared papers)
- Journals
- Frontiers in Oncology (2 papers)The FASEB Journal (2 papers)Cancer Letters (2 papers)FEBS Letters (1 paper)BMC Urology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Wenxia Si
14 papers receiving 341 citations
Peers
Comparison fields: 5 of 59
- Cancer Research 160
- Molecular Biology 211
- Oncology 36
- Cardiology and Cardiovascular Medicine 29
- Cell Biology 21
Countries citing papers authored by Wenxia Si
This map shows the geographic impact of Wenxia Si's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenxia Si with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenxia Si more than expected).
Fields of papers citing papers by Wenxia Si
This network shows the impact of papers produced by Wenxia Si. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenxia Si. The network helps show where Wenxia Si may publish in the future.
Co-authors
The 25 scholars most cited alongside Wenxia Si, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 169 | |
| 2 | 2014 | 38 | |
| 3 | 2013 | 37 | |
| 4 | 2018 | 23 | |
| 5 | 2019 | 22 | |
| 6 | 2020 | 19 | |
| 7 | 2021 | 10 | |
| 8 | 2023 | 9 | |
| 9 | 2020 | 5 | |
| 10 | 2021 | 5 | |
| 11 | 2024 | 3 | |
| 12 | 2023 | 2 | |
| 13 | 2018 | 1 | |
| 14 | 2025 | 1 | |
| 15 | 2025 | 0 | |
| 16 | 2026 | 0 | |
| 17 | 2025 | 0 |
About Wenxia Si
Wenxia Si is a scholar working on Molecular Biology, Cancer Research, Cardiology and Cardiovascular Medicine, Oncology and Pharmacology, having authored 17 papers that have together received 344 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (4 papers), MicroRNA in disease regulation (3 papers), Ubiquitin and proteasome pathways (2 papers), Renin-Angiotensin System Studies (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Cancer-related molecular mechanisms research (2 papers), Apelin-related biomedical research (1 paper) and Ferroptosis and cancer prognosis (1 paper). The work is most often cited by research in Cancer Research (160 citations), Molecular Biology (211 citations), Oncology (36 citations), Cardiology and Cardiovascular Medicine (29 citations) and Cell Biology (21 citations). Wenxia Si has collaborated with scholars based in China and United States. Frequent co-authors include Bisheng Zhou, Xu Yan, Xin Tu, Sisi Li, Ruihua Ma, Qing Wang, Zhenhong Su, Qing K. Wang, Chengqi Xu and Xin Tu. Their work appears in journals such as Frontiers in Oncology, The FASEB Journal, Cancer Letters, FEBS Letters and BMC Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.